Competition Drives Down Prices of Weight-Loss Drugs in Britain

Online pharmacies and slimming clinics in Britain are slashing prices for weight-loss drugs like Wegovy and Mounjaro as initial supply shortages ease, sparking competition in the market.

Self-paying patients, a significant source of revenue for Novo Nordisk’s Wegovy and Eli Lilly’s rival Mounjaro, are being targeted by retailers as demand for the new obesity drugs continues to grow.

Price Reductions and Demand Surge:

Retailers such as Simple Online Pharmacy have reduced prices for Mounjaro starter doses, responding to unprecedented demand and improved supply chains. 

Other clinics like Mayfair Weight Loss Clinic and London Slimming Clinic have also followed suit with price cuts for either Mounjaro or Wegovy.

Market Dynamics and Consumer Behavior:

As the market opens up after initial supply constraints, pharmacies with online platforms are vying for customers by offering competitive deals. 

Patients like Tasha, who purchase Mounjaro through Simple Online Pharmacy, actively seek better prices, reflecting the impact of the cost-of-living crisis.